Use of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML)
NCT00257647
·
clinicaltrials.gov ↗
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Chronic Myeloid Leukemia
Interventions
OTHER:
SV40 vectors carrying siRNA
Sponsor
Hadassah Medical Organization
Collaborators
[object Object]